Sign In
Buy NVS
$153.38
+4.45 (+2.99%)
At Close: Jun 23, 2026
Novartis CEO renews commitment to Sandoz generics unit
04:56am, Tuesday, 26'th Jan 2021
Novartis Chief Executive Vas Narasimhan on Tuesday renewed his commitment to his Sandoz generic unit where sales growth in 2020 stagnated due to reduced hospital stays during the COVID-19 pandemic.
Novartis CEO: Hopeful to Accelerate Growth in Second Half
03:20am, Tuesday, 26'th Jan 2021
Jan.26 -- Vas Narasimhan, chief executive officer at Novartis AG, discusses his outlook for the second half of the year, the vaccine rollout and the long-term impact of Covid-19. He speaks on “Bloom
